Concepedia

Publication | Closed Access

1619O High clinical benefit rates of single agent pembrolizumab in selected rare sarcoma histotypes: First results of the AcSé Pembrolizumab study

DOI

14

Citations

0

References

2020

Year

Jean‐Yves Blay, Sylvie Chevret, Nicolas Penel, François Bertucci, Emmanuelle Bompas, Esma Saâda-Bouzid, J-C. Eymard, JP Lotz, Elodie Coquan, Roland Schött,
Annals of Oncology

No additional data available for this publication yet. Check back later!